Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Correction to: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma

Fig. 1

ACTN1 is highly expressed in HCC tissues and predicts a poor prognosis in HCC patients. a The mRNA expression level of ACTN1 in 20 paired HCC and NCL tissues was analyzed by real-time qPCR. b The protein expression level of ACTN1 in 5 paired HCC and NCL tissues. c Representative immunohistochemical images of ACTN1 in HCC, thrombus, NCL and normal liver tissues. Scale bar: 50 μm. d Immunohistochemical staining of ACTN1 in a tissue microarray containing 157 cases of HCC samples. Scale bar: 50 μm. e The expression of ACTN1 was up-regulated in 74% of HCC patients. f-g Kaplan-Meier curve analysis of overall survival (OS) and disease-free survival (DFS) in HCC patients based on the expression of ACTN1. h Kaplan-Meier curve analysis of OS in TCGA cohort based on the expression of ACTN1. **P < 0.01

Back to article page